NEW STUDY: ENHANCING MICROTESE SUCCESS, PROLISTEM SUPPLEMENT FOR NON-OBSTRUCTIVE AZOOSPERMIA
OBJECTIVE To evaluate the efficacy of Prolistem, a novel supplement, in enhancing MicroTESE success rates for men with non-obstructive azoospermia…
Prolistem® is a fertility support solution that can significantly enhance the chances of sperm production for men with non-obstructive azoospermia (primary testicular failure). Prolistem® is Formulated by experts, patented and FDA-certified.
Prolistem® does it like rebooting your smartphone to fix glitches. Our six-month program has two steps: first, we create the perfect setting for sperm production by temporarily lowering testosterone. Then, in phase two, we bring testosterone back to normal, promoting robust and healthy sperm production. It’s like hitting a refresh button for your fertility journey!
The outcome of research about non-obstructive azoospermia,
Testosterone and Spermatogonial Stem Cell
Dr. Abuelhija is a well-respected member of the scientific community who has been working in reproductive research since 2004. During this time, he has obtained a BSc, MSc, and Ph.D., and has published many scientific papers about his findings. Dr. Abuelhija has collaborated with some of the best scientific minds to ensure Prolistem® is one of the best fertility supplements on the market, helping men with azoospermia have children.
OBJECTIVE To evaluate the efficacy of Prolistem, a novel supplement, in enhancing MicroTESE success rates for men with non-obstructive azoospermia…
We are honored to participate in the highly anticipated ESHRE 2024 Conference, a global stage where the future of reproductive…
We are honored to participate in the prestigious ASRM 2024 Conference in Denver, Colorado, a cornerstone event in the world…
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2025 Prolistem®
PROLISTEM® is a Patented Formula
Copyright © 2025 Prolistem®
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2025 Prolistem®
